by In2Pharma | Jun 7, 2019 | News
Belgium The FAMHP has published a news item on their website concerning payments to the FAMHP. From now on, the FAMHP will send out invoices with structured message for most of its services. As a result, companies will no longer need to make advance payments (via an...
by In2Pharma | Jun 7, 2019 | News
Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...
by In2Pharma | May 14, 2019 | News
The Netherlands On 30 April 2019, the concept text for the Healthcare Transparency Register law was presented for consultation. With this concept law, the obligation for suppliers of medicines and medical devices to report financial relationships with healthcare...
by In2Pharma | May 14, 2019 | News
The Netherlands In the Netherlands, the court has ruled on a case in which a medical search term led to a Google Ad for a food supplement. The court decided that this is unacceptable publicity for medicines. The Google Ad for the food supplement appeared after typing...
by In2Pharma | May 9, 2019 | News
The Netherlands The Medicines Evaluation Board (MEB) will no longer publish full product information about the active substance of generic medicines on its website if there is still a patent on one of the indications. A generic drug may not be sold for indications...
